In the last trading session, 6.78 million shares of the Virpax Pharmaceuticals Inc (NASDAQ:VRPX) were traded, and its beta was 0.96. Most recently the company’s share price was $0.20, and it changed around -$0.04 or -17.29% from the last close, which brings the market valuation of the company to $3.64M. VRPX currently trades at a discount to its 52-week high of $5.48, offering almost -2640.0% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has fallen by an impressive -10.0% since then.

Virpax Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended VRPX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Virpax Pharmaceuticals Inc is expected to report earnings per share of 0 for the current quarter.

Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information

Instantly VRPX has showed a red trend with a performance of -17.29% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2900 on recent trading dayincreased the stock’s daily price by 31.03%. The company’s shares are currently down -47.75% year-to-date, but still down -21.23% over the last five days. On the other hand, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is -36.32% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 93.33% from its current value. Analyst projections state that VRPX is forecast to be at a low of $3 and a high of $3.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -20.69%.

VRPX Dividends

Virpax Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in April.

Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 25.31 shares worth $5023.0, making up 0.17% of all outstanding shares. On the other hand, Fidelity Total Market Index Fund held roughly 8.76 shares worth around $1738.0, which represents about 0.06% of the total shares outstanding.